As you may have seen from the official IASLC announcement, the IASLC had to make the difficult decision to transition all of our 2021 live conferences to worldwide virtual events due to the ongoing concerns caused by Coronavirus Disease (COVID-19). This includes the Targeted Therapies of Lung Cancer Meeting, now virtually taking place February 17 – 21, 2021.
The IASLC Targeted Therapies of Lung Cancer meeting is a dynamic meeting with a long tradition. And while this is the first time it will be delivered as a virtual event, we are looking forward to more than 600 participants to share information about ongoing clinical trials of the newest therapies for lung cancer. Meeting presenters will summarize the data on relevant targets for new therapies and share data on preclinical and early clinical data for each of the drugs directed against these targets. All sessions will include an extended Live Q&A with presenters and world-renowned panelists.
We hope you will be part of the first TTLC Virtual Meeting.
TTLC 2021 Meeting Chairs
Paul A. Bunn, Jr., MD
Roy Herbst, MD, PhD
Suresh S. Ramalingam, MD
Lecia Sequist, MD
Healthcare professionals who diagnose and treat patients with lung cancer, including medical oncologists, thoracic surgeons, pulmonologists, radiation oncologists, radiologists, pathologists and advanced practice nurses and physicians' assistants.
Keep up to date with the latest news & alerts. Sign Up